HomeCompareVSTO vs JNJ

VSTO vs JNJ: Dividend Comparison 2026

VSTO yields 4.48% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $3.5K in total portfolio value· pulled ahead in Year 9
10 years
VSTO
VSTO
● Live price
4.48%
Share price
$44.63
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.8K
Annual income
$597.22
Full VSTO calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — VSTO vs JNJ

📍 JNJ pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVSTOJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VSTO + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VSTO pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VSTO
Annual income on $10K today (after 15% tax)
$380.91/yr
After 10yr DRIP, annual income (after tax)
$507.64/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,478.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VSTO + JNJ for your $10,000?

VSTO: 50%JNJ: 50%
100% JNJ50/50100% VSTO
Portfolio after 10yr
$28.5K
Annual income
$2,643.31/yr
Blended yield
9.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VSTO
Analyst Ratings
14
Buy
10
Hold
Consensus: Buy
Price Target
$40.00
-10.4% upside vs current
Range: $37.00 — $43.00
Altman Z
2.8
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VSTO buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVSTOJNJ
Forward yield4.48%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$26.8K$30.3K
Annual income after 10y$597.22$4,689.40
Total dividends collected$5.3K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$40.00$228.73

Year-by-year: VSTO vs JNJ ($10,000, DRIP)

YearVSTO PortfolioVSTO Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,148$448.13$10,592$272.30+$556.00VSTO
2$12,395$466.90$11,289$357.73+$1.1KVSTO
3$13,748$485.17$12,123$472.89+$1.6KVSTO
4$15,214$502.92$13,141$629.86+$2.1KVSTO
5$16,799$520.11$14,408$846.81+$2.4KVSTO
6$18,511$536.73$16,021$1,151.60+$2.5KVSTO
7$20,360$552.76$18,122$1,588.22+$2.2KVSTO
8$22,353$568.19$20,930$2,228.20+$1.4KVSTO
9← crossover$24,501$583.00$24,792$3,191.91$291.00JNJ
10$26,813$597.22$30,274$4,689.40$3.5KJNJ

VSTO vs JNJ: Complete Analysis 2026

VSTOStock

Vista Outdoor Inc. designs, manufactures, and markets consumer products in the outdoor sports and recreation markets in the United States and internationally. The company operates through two segments, Sporting Products and Outdoor Products. The Sporting Products segment designs, develops, manufactures, and distributes ammunitions, components, and related equipment and accessories that serves hunters, recreational shooters, federal and local law enforcement agencies, and military. This segment products include ammunition products, such as pistol, rifle, rimfire, and shotshell ammunition, as well as components. The Outdoor Products segment offers gears and equipment that enhances the outdoor experiences of a wide variety of end users, including hunters, hikers, campers, cyclists, skiers, snowboarders, and golfers. This segments products portfolio includes hunting and shooting accessories comprising reloading equipment, clay targets, premium gun care products, hunting arrows, game calls, hunting blinds, and decoys; optics, such as binoculars, riflescopes, game cameras, and telescopes; tactical accessories comprising holsters, duty gear, bags, and packs; personal hydration solutions consist of hydration packs, water bottles, and drinkware; outdoor cooking solutions, including grills, cookware, pellets, and camp stoves; helmets, goggles, footwear, E-bikes, and accessories for cycling, snow sports, action sports, and power sports; audio speakers for outdoor sports; and golf gps devices, laser rangefinders, golf launch monitors and simulators, and other golf technology products. The company sells its products to outdoor enthusiasts, backyard grillers, campers, and athletes, as well as law enforcement and military professionals through a wide variety of mass, specialty, and independent retailers and distributors, as well as consumers through brand's website. Vista Outdoor Inc. was incorporated in 2014 and is headquartered in Anoka, Minnesota.

Full VSTO Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this VSTO vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VSTO vs SCHDVSTO vs JEPIVSTO vs OVSTO vs KOVSTO vs MAINVSTO vs ABBVVSTO vs MRKVSTO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.